Cycle Race a Contradiction?
An excerpt from Wired News:
Amgen, the maker of Erythropoietin, the banned substance that's the scourge of cycling, is the unlikely sponsor of the Tour of California, the prestigious race currently underway in the Golden State.
Performance-boosting Erythropoietin, or EPO, is the No. 1 target of the World Anti-Doping Agency and the sport's big skeleton in the closet. The group has openly questioned Amgen's motives for sponsoring the Tour. In a November 2005 statement, WADA asked, "What sort of message does this send to our athletes?"
But the drugmaker doesn't see a contradiction in its sponsorship of a major cycling event.
"We think sponsoring the Tour is completely in line with our mission," said Mary Klem, spokeswoman for biotech firm Amgen. "We're using the event as a forum to warn against blood doping and (to) tell everyone how dangerous and unhealthy it can be for both professionals and amateurs."